| Ident. | Authors (with country if any) | Title |
|---|
| 000032 (2020) |
Ming Niu [République populaire de Chine] ; Rui-Lin Wang [République populaire de Chine] ; Zhong-Xia Wang [République populaire de Chine] ; Ping Zhang [République populaire de Chine] ; Zhao-Fang Bai [République populaire de Chine] ; Jing Jing [République populaire de Chine] ; Yu-Ming Guo [République populaire de Chine] ; Xu Zhao [République populaire de Chine] ; Xiao-Yan Zhan [République populaire de Chine] ; Zi-Teng Zhang [République populaire de Chine] ; Xue-Ai Song [République populaire de Chine] ; En-Qiang Qin [République populaire de Chine] ; Jia-Bo Wang [République populaire de Chine] ; Xiao-He Xiao [République populaire de Chine] | [Rapid establishment of traditional Chinese medicine prevention and treatment of 2019-nCoV based on clinical experience and molecular docking]. |
| 000472 (2020) |
Jiahua He [République populaire de Chine] ; Huanyu Tao [République populaire de Chine] ; Yumeng Yan [République populaire de Chine] ; Sheng-You Huang [République populaire de Chine] ; Yi Xiao [République populaire de Chine] | Molecular Mechanism of Evolution and Human Infection with SARS-CoV-2. |
| 000474 (2020) |
Paolo Calligari [Italie] ; Sara Bobone [Italie] ; Giorgio Ricci [Italie] ; Alessio Bocedi [Italie] | Molecular Investigation of SARS-CoV-2 Proteins and Their Interactions with Antiviral Drugs. |
| 000991 (2020) |
Abdo A. Elfiky | Anti-HCV, nucleotide inhibitors, repurposing against COVID-19 |
| 000A86 (2019) |
Kaijun Jin [République populaire de Chine] ; Yali Sang [République populaire de Chine] ; Sheng Han [République populaire de Chine] ; Erik De Clercq [Belgique] ; Christophe Pannecouque [Belgique] ; Ge Meng [République populaire de Chine] ; Fener Chen [République populaire de Chine] | Synthesis and biological evaluation of dihydroquinazoline-2-amines as potent non-nucleoside reverse transcriptase inhibitors of wild-type and mutant HIV-1 strains. |
| 000B45 (2019) |
Kouji Ohnishi [Japon] ; Yasunao Hattori [Japon] ; Kazuya Kobayashi [Japon] ; Kenichi Akaji [Japon] | Evaluation of a non-prime site substituent and warheads combined with a decahydroisoquinolin scaffold as a SARS 3CL protease inhibitor. |
| 000C19 (2018) |
Xueyi Lu [République populaire de Chine] ; Jiapei Yang [République populaire de Chine] ; Dongwei Kang [République populaire de Chine] ; Ping Gao [République populaire de Chine] ; Dirk Daelemans [Belgique] ; Erik De Clercq [Belgique] ; Christophe Pannecouque [Belgique] ; Peng Zhan [République populaire de Chine] ; Xinyong Liu [République populaire de Chine] | The discovery of novel diarylpyri(mi)dine derivatives with high level activity against a wide variety of HIV-1 strains as well as against HIV-2. |
| 000C51 (2018) |
Hsu-Feng Chu [Taïwan] ; Chiao-Che Chen [Taïwan] ; David C. Moses [Taïwan] ; Yau-Hung Chen [Taïwan] ; Chao-Hsiung Lin [Taïwan] ; Ying-Chieh Tsai [Taïwan] ; Chi-Yuan Chou [Taïwan] | Porcine epidemic diarrhea virus papain-like protease 2 can be noncompetitively inhibited by 6-thioguanine |
| 000C92 (2018) |
Zhongxia Zhou [République populaire de Chine] ; Tao Liu ; Dongwei Kang ; Zhipeng Huo ; Gaochan Wu ; Dirk Daelemans ; Erik De Clercq ; Christophe Pannecouque ; Peng Zhan ; Xinyong Liu | Discovery of novel diarylpyrimidines as potent HIV-1 NNRTIs by investigating the chemical space of a less explored "hydrophobic channel". |
| 000C95 (2018) |
Rakhi Gawali [Inde] ; Jay Trivedi [Inde] ; Sujit Bhansali [Inde] ; Raghunath Bhosale [Inde] ; Dhiman Sarkar [Inde] ; Debashis Mitra [Inde] | Design, synthesis, docking studies and biological screening of 2-thiazolyl substituted -2,3-dihydro-1H-naphtho[1,2-e][1,3]oxazines as potent HIV-1 reverse transcriptase inhibitors. |
| 000D81 (2017) |
Abdo A. Elfiky [Égypte] ; Samah M. Mahdy [Égypte] ; Wael M. Elshemey [Égypte] | Quantitative structure-activity relationship and molecular docking revealed a potency of anti-hepatitis C virus drugs against human corona viruses. |
| 000E31 (2017) |
Jana Humpolickova [République tchèque] ; Ivana Mejdrová [République tchèque] ; Marika Matousova [République tchèque] ; Radim Nencka [République tchèque] ; Evzen Boura [République tchèque] | Fluorescent Inhibitors as Tools To Characterize Enzymes: Case Study of the Lipid Kinase Phosphatidylinositol 4-Kinase IIIβ (PI4KB). |
| 000E50 (2017) |
Li Wang [République populaire de Chine] ; Bo-Bo Bao [République populaire de Chine] ; Guo-Qing Song [République populaire de Chine] ; Cheng Chen [République populaire de Chine] ; Xu-Meng Zhang [République populaire de Chine] ; Wei Lu [République populaire de Chine] ; Zefang Wang [République populaire de Chine] ; Yan Cai [République populaire de Chine] ; Shuang Li [République populaire de Chine] ; Sheng Fu [République populaire de Chine] ; Fu-Hang Song [République populaire de Chine] ; Haitao Yang [République populaire de Chine] ; Jian-Guo Wang [République populaire de Chine] | Discovery of unsymmetrical aromatic disulfides as novel inhibitors of SARS-CoV main protease: Chemical synthesis, biological evaluation, molecular docking and 3D-QSAR study |
| 000F37 (2016) |
Gaopeng Song [République populaire de Chine] ; Xintian Shen [République populaire de Chine] ; Sumei Li [République populaire de Chine] ; Yibin Li [République populaire de Chine] ; Hongzong Si [République populaire de Chine] ; Jihong Fan [République populaire de Chine] ; Junhua Li [République populaire de Chine] ; Erqiang Gao [République populaire de Chine] ; Shuwen Liu [République populaire de Chine] | Structure-activity relationships of 3-O-β-chacotriosyl oleanane-type triterpenoids as potential H5N1 entry inhibitors. |
| 001007 (2016) |
Vathan Kumar [Taïwan] ; Kian-Pin Tan [Taïwan] ; Ying-Ming Wang [Taïwan] ; Sheng-Wei Lin [Taïwan] ; Po-Huang Liang [Taïwan] | Identification, synthesis and evaluation of SARS-CoV and MERS-CoV 3C-like protease inhibitors. |
| 001049 (2016) |
Sheng Liu [République populaire de Chine] ; Yubin Li [République populaire de Chine] ; Wanxing Wei [République populaire de Chine] ; Kuiwu Wang [République populaire de Chine] ; Lisheng Wang [République populaire de Chine] ; Jianyi Wang [République populaire de Chine] | Design, synthesis, molecular docking studies and anti-HBV activity of phenylpropanoid derivatives. |
| 001052 (2016) |
Jiapei Yang [République populaire de Chine] ; Wenmin Chen [République populaire de Chine] ; Dongwei Kang [République populaire de Chine] ; Xueyi Lu [République populaire de Chine] ; Xiao Li [République populaire de Chine] ; Zhaoqiang Liu [République populaire de Chine] ; Boshi Huang [République populaire de Chine] ; Dirk Daelemans [Belgique] ; Christophe Pannecouque [Belgique] ; Erik De Clercq [Belgique] ; Peng Zhan [République populaire de Chine] ; Xinyong Liu [République populaire de Chine] | Design, synthesis and anti-HIV evaluation of novel diarylpyridine derivatives targeting the entrance channel of NNRTI binding pocket. |
| 001053 (2016) |
Hiroyuki Konno [Japon] ; Masaki Wakabayashi [Japon] ; Daiki Takanuma [Japon] ; Yota Saito [Japon] ; Kenichi Akaji [Japon] | Design and synthesis of a series of serine derivatives as small molecule inhibitors of the SARS coronavirus 3CL protease |
| 001231 (2015) |
Yuanyuan Cao [République populaire de Chine] ; Yu Zhang [République populaire de Chine] ; Shaotong Wu [République populaire de Chine] ; Quanzhi Yang [République populaire de Chine] ; Xuefeng Sun [République populaire de Chine] ; Jianxiong Zhao [République populaire de Chine] ; Fen Pei [République populaire de Chine] ; Ying Guo [République populaire de Chine] ; Chao Tian [République populaire de Chine] ; Zhili Zhang [République populaire de Chine] ; Haining Wang [République populaire de Chine] ; Liying Ma [République populaire de Chine] ; Junyi Liu [République populaire de Chine] ; Xiaowei Wang [République populaire de Chine] | Synthesis and biological evaluation of pyridinone analogues as novel potent HIV-1 NNRTIs. |
| 001269 (2015) |
Michael Berry [Afrique du Sud] ; Burtram C. Fielding [Afrique du Sud] ; Junaid Gamieldien [Afrique du Sud] | Potential Broad Spectrum Inhibitors of the Coronavirus 3CLpro: A Virtual Screening and Structure-Based Drug Design Study. |
| 001289 (2015) |
Sakshi Tomar ; Melanie L. Johnston [États-Unis] ; Sarah E. St John ; Heather L. Osswald [États-Unis] ; Prasanth R. Nyalapatla [États-Unis] ; Lake N. Paul ; Arun K. Ghosh [États-Unis] ; Mark R. Denison [États-Unis] ; Andrew D. Mesecar [États-Unis] | Ligand-induced Dimerization of Middle East Respiratory Syndrome (MERS) Coronavirus nsp5 Protease (3CLpro): IMPLICATIONS FOR nsp5 REGULATION AND THE DEVELOPMENT OF ANTIVIRALS. |
